BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,081 filers reported holding BAXTER INTL INC in Q1 2019. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $487,959 | -17.5% | 12,933 | -0.4% | 0.02% | -15.0% |
| Q2 2023 | $591,637 | +13.3% | 12,986 | +0.9% | 0.02% | +5.3% |
| Q1 2023 | $522,001 | -20.5% | 12,870 | -0.1% | 0.02% | -26.9% |
| Q4 2022 | $656,539 | -5.4% | 12,881 | 0.0% | 0.03% | -13.3% |
| Q3 2022 | $694,000 | +438.0% | 12,881 | +538.0% | 0.03% | +500.0% |
| Q2 2022 | $129,000 | +55.4% | 2,019 | +89.0% | 0.01% | +66.7% |
| Q1 2022 | $83,000 | -9.8% | 1,068 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $92,000 | +7.0% | 1,068 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $86,000 | +1.2% | 1,068 | +1.2% | 0.00% | 0.0% |
| Q2 2021 | $85,000 | -4.5% | 1,055 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $89,000 | +4.7% | 1,055 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $85,000 | +1.2% | 1,055 | +0.3% | 0.00% | -20.0% |
| Q3 2020 | $84,000 | -7.7% | 1,052 | 0.0% | 0.01% | -16.7% |
| Q2 2020 | $91,000 | +7.1% | 1,052 | -0.3% | 0.01% | -14.3% |
| Q1 2020 | $85,000 | -3.4% | 1,055 | +0.3% | 0.01% | +16.7% |
| Q4 2019 | $88,000 | -4.3% | 1,052 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $92,000 | +17.9% | 1,052 | +10.6% | 0.01% | 0.0% |
| Q2 2019 | $78,000 | +1.3% | 951 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $77,000 | +22.2% | 951 | 0.0% | 0.01% | +20.0% |
| Q4 2018 | $63,000 | -13.7% | 951 | +0.3% | 0.01% | 0.0% |
| Q3 2018 | $73,000 | +4.3% | 948 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $70,000 | +12.9% | 948 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $62,000 | +1.6% | 948 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $61,000 | +1.7% | 948 | 0.0% | 0.01% | -16.7% |
| Q3 2017 | $60,000 | +5.3% | 948 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $57,000 | +14.0% | 948 | 0.0% | 0.01% | +20.0% |
| Q1 2017 | $50,000 | +19.0% | 948 | 0.0% | 0.01% | +25.0% |
| Q4 2016 | $42,000 | -6.7% | 948 | 0.0% | 0.00% | -20.0% |
| Q3 2016 | $45,000 | +4.7% | 948 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $43,000 | +10.3% | 948 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $39,000 | -17.0% | 948 | -24.0% | 0.01% | -16.7% |
| Q4 2015 | $47,000 | -16.1% | 1,248 | -26.5% | 0.01% | -14.3% |
| Q3 2015 | $56,000 | -54.1% | 1,698 | -2.9% | 0.01% | -50.0% |
| Q2 2015 | $122,000 | +1.7% | 1,748 | 0.0% | 0.01% | +7.7% |
| Q1 2015 | $120,000 | -6.2% | 1,748 | 0.0% | 0.01% | -7.1% |
| Q4 2014 | $128,000 | +2.4% | 1,748 | 0.0% | 0.01% | 0.0% |
| Q3 2014 | $125,000 | -0.8% | 1,748 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $126,000 | -2.3% | 1,748 | 0.0% | 0.01% | -6.7% |
| Q1 2014 | $129,000 | +5.7% | 1,748 | 0.0% | 0.02% | 0.0% |
| Q4 2013 | $122,000 | +6.1% | 1,748 | 0.0% | 0.02% | 0.0% |
| Q3 2013 | $115,000 | -5.0% | 1,748 | 0.0% | 0.02% | -11.8% |
| Q2 2013 | $121,000 | – | 1,748 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |